Rayyan

Rayyan is an AI-powered systematic review platform built for academic researchers, evidence synthesis teams, clinicians, and public health researchers conducting systematic literature reviews and meta-analyses. Originally developed by the Qatar Computing Research Institute (QCRI) and now operated by Rayyan Systems Inc., the platform has grown into one of the most widely adopted systematic review tools globally, with 1M+ researchers across 20,000+ academic, healthcare, and research institutions. Core capabilities include AI-powered duplicate detection, widely regarded as best-in-category for systematic reviews. The Predictor engine learns researcher inclusion and exclusion patterns and ranks remaining papers by relevance, and the platform adds multi-reviewer collaboration with conflict resolution, full-text screening, PRISMA flow diagram generation, and iOS and Android apps with offline support. Best fit: academic research teams conducting systematic reviews and meta-analyses; public health and clinical researchers following PRISMA standards; evidence synthesis teams at universities, hospitals, and research institutions; and individual graduate students needing a free entry point into systematic review tooling. Rayyan integrates natively with the three most widely used academic reference managers: Zotero (direct import), Mendeley (direct import), and EndNote (direct import), removing the manual export step for researchers already managing citations in those tools. RIS and BibTeX import and export support any additional reference manager. PRISMA flow diagram generation is built in for compliance documentation. iOS and Android mobile apps support offline screening with automatic sync on reconnect. Library research guides at the University of Hawaii, University of Mississippi, University of South Africa, and University of Georgia recommend Rayyan as a standard systematic review tool, reflecting broad institutional endorsement across academic libraries. No official MCP server has been published as of Q3 2026. API access is available on the Institutional tier only. Named integration gaps: no direct search import from PubMed, Scopus, or Web of Science (manual export required), no Overleaf integration for manuscript workflows, and no Zapier or Make connector for workflow automation. Rayyan offers a freemium model with publicly listed individual tiers and custom institutional pricing. Free ($0/month): 3 active reviews, up to 2 reviewers/viewers, AI duplicate detection, Legacy Compute Rating, workbench with 15+ facets and filters, and standard support. Mobile app screening on the free tier is limited to 100 decisions on reviews you own. Essential ($4.99/seat/month annual, $59.88/year): for small teams wanting more collaboration and flexibility; includes everything in Free plus 5 reviewers/viewers across reviews, PRISMA flow diagram generator, auto-resolve duplicates, mobile app access, and multi-select bulk actions. Advanced ($8.33/seat/month annual, $99.99/year): the best-value tier for researchers needing more reviews and power; includes everything in Essential plus 9 active reviews, 10 reviewers/viewers across reviews, PICO extraction (AI), Advanced Compute Rating (AI, in development), and priority support. Annual billing saves up to 40% versus monthly across all paid tiers. Institutional: custom pricing for universities, research institutions, and healthcare organizations with team licensing, advanced features, and dedicated support. Rayyan is not suited for open-domain literature discovery or AI-generated research synthesis beyond systematic review workflows. For AI-generated reports synthesizing web sources, Gemini Deep Research (free tier; $19.99/mo Pro) or ChatGPT Deep Research ($20/mo) cover broader source territory. For citation context analysis showing whether papers support or contradict each other, Scite.ai ($12/mo billed annually) provides Smart Citations that Rayyan does not include. For depth-first academic literature search that follows citation trails and generates annotated reports, Undermind ($16/mo billed annually) targets a similar academic audience with deeper autonomous search. Enterprise systematic review teams with high-stakes regulatory or clinical evidence synthesis needs may require Covidence (from $149/month) or DistillerSR (custom pricing), which provide more advanced workflow customization, audit trails, and enterprise-grade reporting than the Advanced tier covers. Google Play reviewers note friction around the 100-decision mobile limit on the free tier and unexpected payment requirements for invited collaborators on reviews where only the review owner holds a paid subscription. Rayyan maintains its position as the leading free systematic review platform globally with 1M+ users per the vendor homepage, validated by a PMC/NIH peer-reviewed study confirming 97-99% AI screening sensitivity for abstract screening in diagnostic test accuracy reviews. The platform is endorsed in university library research guides at multiple major academic institutions and continues to serve as the standard free-tier entry point for systematic review methodology globally. No MCP server has been published as of Q3 2026. Google Play shows 3.2/5 from 227 reviews and 50K+ downloads, with user feedback noting friction around the mobile free-tier decision limit and collaborator payment requirements. Annual Advanced pricing at $8.33/seat/month and Essential pricing at $4.99/seat/month remain substantially below Covidence ($149+/month) and DistillerSR (custom pricing), maintaining the accessibility positioning that distinguishes Rayyan from enterprise-only competitors.